Hepatitis B is the deadliest form of hepatitis by a wide margin. It accounts for 83% of the 1.3 million viral hepatitis deaths that occur globally each year, making it the second leading infectious killer worldwide, on par with tuberculosis. Hepatitis C causes most of the remaining deaths. But the answer gets more nuanced when you look at specific situations: hepatitis D accelerates liver damage faster than any other type, and hepatitis E is uniquely lethal during pregnancy.
Hepatitis B: The Biggest Global Killer
Hepatitis B is responsible for roughly 3,500 deaths per day worldwide, combining deaths from both B and C. Of those, B claims the lion’s share. The virus spreads through blood, sexual contact, shared needles, and from mother to child during birth. What makes it so dangerous is its ability to become a lifelong infection, particularly when acquired early in life. Babies infected at birth have about a 95% chance of developing chronic hepatitis B, while adults who contract the virus clear it on their own roughly 95% of the time.
That distinction matters enormously. Chronic hepatitis B slowly damages the liver over decades, leading to cirrhosis and liver cancer. Hepatitis B and C together account for 75% of all primary liver cancer cases worldwide, with hepatitis B alone responsible for about 15% to 20% of those cases globally. In regions where the virus is most common, particularly sub-Saharan Africa and East Asia, many people are infected at birth and carry the virus for life without knowing it until serious liver damage has already occurred.
The good news: an effective vaccine exists and provides protection for at least 30 years when given in infancy. In countries with high vaccination coverage, new infections have dropped dramatically. But for the hundreds of millions already living with chronic hepatitis B, the virus remains a slow-moving threat.
Hepatitis C: Curable but Still Deadly
Hepatitis C causes about 17% of global viral hepatitis deaths, roughly 220,000 per year. It spreads primarily through blood, most commonly via shared needles or, in earlier decades, contaminated blood transfusions. Unlike hepatitis B, there is no vaccine for hepatitis C. However, it now has something hepatitis B does not: a cure. Modern antiviral treatments can eliminate the virus in the vast majority of patients, typically with an 8- to 12-week course of pills.
The challenge is that hepatitis C often causes no symptoms for years or even decades. Many people don’t know they’re infected until they develop cirrhosis or liver cancer. In fact, hepatitis C is the single largest contributor to liver cancer in many Western countries, linked to roughly 47% of all primary liver cancer cases. The virus becomes chronic in a much higher proportion of infected adults than hepatitis B does. Without treatment, the long-term damage can be severe.
Hepatitis D: The Most Aggressive Form
Hepatitis D is arguably the most severe type on a case-by-case basis, even though it affects fewer people overall. It can only infect someone who already has hepatitis B, because it hijacks the hepatitis B virus to replicate. This dual infection accelerates liver damage dramatically. In one long-term study, 77% of patients with both hepatitis B and D showed worsening liver disease, compared to just 30% of those with hepatitis B alone. Seven out of ten patients who progressed to cirrhosis did so within the first two years.
Hepatitis D spreads the same way as hepatitis B, through blood and body fluids, and it requires only a tiny amount of virus to cause infection. Treatment options are limited, and the combination of B and D is harder to manage than either virus alone. The hepatitis B vaccine indirectly prevents hepatitis D, since you can’t get D without B. But for people already living with chronic hepatitis B, a D coinfection is the worst-case scenario for liver health.
Hepatitis A and E: Usually Mild, With Exceptions
Hepatitis A and E are fundamentally different from B, C, and D. Both spread through contaminated food and water rather than blood, and neither causes chronic infection. Most healthy adults recover fully within weeks to months.
Hepatitis A rarely causes serious complications. The risk of acute liver failure from hepatitis A is low, around 2% in studies of acute viral hepatitis cases. That number jumps significantly, though, for people who already carry hepatitis B. In one study, the rate of fulminant (sudden, severe) liver failure reached 10.6% in hepatitis B carriers who then caught acute hepatitis A or another virus on top of it.
Hepatitis E is similarly mild for most people but carries a specific and alarming risk for pregnant women. Infection with certain strains during the third trimester of pregnancy can cause maternal death in 15% to 25% of cases, a fatality rate that far exceeds any other hepatitis type in that population. Outside of pregnancy, hepatitis E resolves on its own in the vast majority of cases. No widely available vaccine exists for hepatitis E, and prevention relies mostly on clean water and sanitation.
How the Five Types Compare
- Hepatitis B: The leading killer overall. Causes 83% of viral hepatitis deaths worldwide. Becomes chronic in 95% of infants infected at birth. Preventable with a highly effective vaccine.
- Hepatitis C: The second leading killer. Causes 17% of viral hepatitis deaths. No vaccine, but curable with modern antivirals. Linked to nearly half of all liver cancer cases.
- Hepatitis D: The most aggressive per individual case. Only occurs alongside hepatitis B. Accelerates cirrhosis dramatically, with most progression happening within two years.
- Hepatitis E: Typically mild, but kills up to 25% of pregnant women infected in their third trimester. Spread through contaminated water.
- Hepatitis A: Least dangerous overall. Almost always resolves without lasting damage. Vaccine available and highly effective.
Why the Answer Depends on Context
If you’re asking which hepatitis virus kills the most people, the answer is hepatitis B, and it’s not close. If you’re asking which causes the fastest liver destruction in an individual patient, hepatitis D coinfection is worse. If you’re asking which is most dangerous during pregnancy, hepatitis E stands alone. And if you’re asking which poses the greatest ongoing risk in countries with strong healthcare systems, hepatitis C remains a major concern because so many infections go undiagnosed for decades.
The practical takeaway is that hepatitis B vaccination, now routine for newborns in most countries, prevents both the biggest killer (B) and the most aggressive form (D). Hepatitis C screening, recommended for all adults at least once, catches a curable disease before it causes irreversible damage. Hepatitis A and E are largely preventable through vaccination (for A) and basic food and water safety (for both).